BruceA. W., MahanD. E., SullivanL. D., GoldenbergL.: The significance of prostatic acid phosphatase in adenocarcinoma of the prostate. J. Urol., 125; 357–360 (1981).
2.
CooperJ. F., FotiA.: A radioimmunoassay for prostatic acid phosphatase, methodology and range of normal serum values. Invest. Urol., 12; 98–102 (1974).
3.
CooperJ. F., FinkleW. D.: Current experience with radioimmunoassay techniques for prostatic acid phosphatase. Prostate, 1; 441–450 (1980).
4.
FotiA., HershmanH., CooperJ. F.: A solid phase ralioimmunoassay for human prostatic acid phosphatase. Cancer Res., 35; 2446–2452 (1975).
5.
GittesR.: Acid phosphatase reappraised. N. Engl. J. Med., 297; 1398–1399 (1977).
6.
QuinonesG. R., RohnerT. J., DragoJ. R., DemersL. M.: Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer?J. Urol., 125; 361–364 (1981).
7.
ReifA. E., SchlesingerR. M., FishC. A.: Acid phosphatase isoenzymes in cancer of the prostate. Cancer, 31; 689–699 (1973).
8.
UICC:TNM Classification of malignant tumours. Third Edition, Geneva1978.
9.
WatsonR. A., TangD. B.: The predictive value of prostatic acid phosphatase as screening test for prostatic cancer. N. Engl. J. Med., 303; 697–699 (1980).
